vs

Side-by-side financial comparison of Harmony Biosciences Holdings, Inc. (HRMY) and RAYONIER INC (RYN). Click either name above to swap in a different company.

RAYONIER INC is the larger business by last-quarter revenue ($276.8M vs $243.8M, roughly 1.1× Harmony Biosciences Holdings, Inc.). Harmony Biosciences Holdings, Inc. runs the higher net margin — 9.2% vs -4.5%, a 13.7% gap on every dollar of revenue. On growth, RAYONIER INC posted the faster year-over-year revenue change (233.9% vs 21.1%). Over the past eight quarters, RAYONIER INC's revenue compounded faster (66.7% CAGR vs 25.6%).

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

Rayonier Inc., headquartered in Wildlight, Florida is a timberland real estate investment trust ("REIT") with assets located in softwood timber growing regions in the United States and New Zealand. Its core business segments are timber and real estate.

HRMY vs RYN — Head-to-Head

Bigger by revenue
RYN
RYN
1.1× larger
RYN
$276.8M
$243.8M
HRMY
Growing faster (revenue YoY)
RYN
RYN
+212.8% gap
RYN
233.9%
21.1%
HRMY
Higher net margin
HRMY
HRMY
13.7% more per $
HRMY
9.2%
-4.5%
RYN
Faster 2-yr revenue CAGR
RYN
RYN
Annualised
RYN
66.7%
25.6%
HRMY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HRMY
HRMY
RYN
RYN
Revenue
$243.8M
$276.8M
Net Profit
$22.5M
$-12.4M
Gross Margin
71.9%
100.0%
Operating Margin
15.8%
Net Margin
9.2%
-4.5%
Revenue YoY
21.1%
233.9%
Net Profit YoY
-54.6%
-264.7%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRMY
HRMY
RYN
RYN
Q1 26
$276.8M
Q4 25
$243.8M
$117.5M
Q3 25
$239.5M
$177.5M
Q2 25
$200.5M
$106.5M
Q1 25
$184.7M
$82.9M
Q4 24
$201.3M
$650.5M
Q3 24
$186.0M
$124.1M
Q2 24
$172.8M
$99.6M
Net Profit
HRMY
HRMY
RYN
RYN
Q1 26
$-12.4M
Q4 25
$22.5M
$25.9M
Q3 25
$50.9M
$43.2M
Q2 25
$39.8M
$408.7M
Q1 25
$45.6M
$-3.4M
Q4 24
$49.5M
$327.1M
Q3 24
$46.1M
$28.8M
Q2 24
$11.6M
$1.9M
Gross Margin
HRMY
HRMY
RYN
RYN
Q1 26
100.0%
Q4 25
71.9%
41.9%
Q3 25
75.1%
32.9%
Q2 25
81.0%
29.7%
Q1 25
82.7%
21.7%
Q4 24
73.0%
53.8%
Q3 24
77.0%
30.4%
Q2 24
81.4%
25.4%
Operating Margin
HRMY
HRMY
RYN
RYN
Q1 26
Q4 25
15.8%
23.0%
Q3 25
27.3%
23.5%
Q2 25
24.0%
13.7%
Q1 25
30.4%
0.1%
Q4 24
27.7%
47.7%
Q3 24
33.2%
15.2%
Q2 24
12.4%
4.6%
Net Margin
HRMY
HRMY
RYN
RYN
Q1 26
-4.5%
Q4 25
9.2%
22.1%
Q3 25
21.2%
24.3%
Q2 25
19.8%
383.6%
Q1 25
24.7%
-4.1%
Q4 24
24.6%
45.1%
Q3 24
24.8%
23.2%
Q2 24
6.7%
1.9%
EPS (diluted)
HRMY
HRMY
RYN
RYN
Q1 26
Q4 25
$0.38
$0.14
Q3 25
$0.87
$0.28
Q2 25
$0.68
$2.63
Q1 25
$0.78
$-0.02
Q4 24
$0.85
$2.18
Q3 24
$0.79
$0.19
Q2 24
$0.20
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRMY
HRMY
RYN
RYN
Cash + ST InvestmentsLiquidity on hand
$775.3M
$681.7M
Total DebtLower is stronger
$163.7M
$2.1B
Stockholders' EquityBook value
$870.2M
$5.3B
Total Assets
$1.3B
$7.7B
Debt / EquityLower = less leverage
0.19×
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRMY
HRMY
RYN
RYN
Q1 26
$681.7M
Q4 25
$775.3M
$842.9M
Q3 25
$672.6M
$919.6M
Q2 25
$565.3M
$892.3M
Q1 25
$507.0M
$216.2M
Q4 24
$467.2M
$303.1M
Q3 24
$410.5M
$51.9M
Q2 24
$346.9M
$120.2M
Total Debt
HRMY
HRMY
RYN
RYN
Q1 26
$2.1B
Q4 25
$163.7M
$845.3M
Q3 25
$168.5M
$845.1M
Q2 25
$172.1M
$844.9M
Q1 25
$175.7M
$1.0B
Q4 24
$179.3M
$1.0B
Q3 24
$182.8M
$1.3B
Q2 24
$186.4M
$1.4B
Stockholders' Equity
HRMY
HRMY
RYN
RYN
Q1 26
$5.3B
Q4 25
$870.2M
$2.2B
Q3 25
$835.1M
$2.3B
Q2 25
$773.1M
$2.3B
Q1 25
$720.5M
$1.9B
Q4 24
$659.2M
$1.8B
Q3 24
$596.8M
$1.8B
Q2 24
$538.6M
$1.8B
Total Assets
HRMY
HRMY
RYN
RYN
Q1 26
$7.7B
Q4 25
$1.3B
$3.4B
Q3 25
$1.2B
$3.5B
Q2 25
$1.1B
$3.5B
Q1 25
$1.1B
$3.4B
Q4 24
$999.2M
$3.5B
Q3 24
$928.1M
$3.5B
Q2 24
$858.4M
$3.5B
Debt / Equity
HRMY
HRMY
RYN
RYN
Q1 26
0.39×
Q4 25
0.19×
0.38×
Q3 25
0.20×
0.37×
Q2 25
0.22×
0.37×
Q1 25
0.24×
0.55×
Q4 24
0.27×
0.59×
Q3 24
0.31×
0.72×
Q2 24
0.35×
0.75×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRMY
HRMY
RYN
RYN
Operating Cash FlowLast quarter
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
7.4%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRMY
HRMY
RYN
RYN
Q1 26
Q4 25
$126.2M
$256.7M
Q3 25
$108.7M
$116.2M
Q2 25
$79.3M
$61.0M
Q1 25
$34.0M
$27.7M
Q4 24
$75.6M
$261.6M
Q3 24
$70.5M
$66.2M
Q2 24
$42.6M
$55.3M
Free Cash Flow
HRMY
HRMY
RYN
RYN
Q1 26
Q4 25
$126.0M
Q3 25
$108.7M
$99.9M
Q2 25
$79.3M
Q1 25
$33.9M
Q4 24
$75.0M
Q3 24
$70.5M
$42.2M
Q2 24
$42.0M
FCF Margin
HRMY
HRMY
RYN
RYN
Q1 26
Q4 25
51.7%
Q3 25
45.4%
56.3%
Q2 25
39.6%
Q1 25
18.3%
Q4 24
37.3%
Q3 24
37.9%
34.0%
Q2 24
24.3%
Capex Intensity
HRMY
HRMY
RYN
RYN
Q1 26
7.4%
Q4 25
0.0%
Q3 25
0.0%
9.2%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.0%
19.3%
Q2 24
0.4%
Cash Conversion
HRMY
HRMY
RYN
RYN
Q1 26
Q4 25
5.61×
9.91×
Q3 25
2.14×
2.69×
Q2 25
1.99×
0.15×
Q1 25
0.75×
Q4 24
1.53×
0.80×
Q3 24
1.53×
2.30×
Q2 24
3.68×
29.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRMY
HRMY

Segment breakdown not available.

RYN
RYN

Wood Products$108.5M39%
Southern Timber$88.7M32%
Real Estate$59.8M22%
Northwest Timber$32.1M12%

Related Comparisons